(Mark One) | ||
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) | (IRS Employer Identification Number) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
☒ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company | Emerging growth company |
For the Three Months Ended March 31, | |||
2024 | 2025 | ||
Consolidated revenue | $ | $ | |
Consolidated expenses: | |||
Compensation and related expenses | |||
Selling, general and administrative | |||
Intangible amortization and impairments | |||
Interest expense | |||
Depreciation and other amortization | |||
Other expenses (net) | |||
Total consolidated expenses | |||
Equity method income (net) | |||
Investment and other income | |||
Income before income taxes | |||
Income tax expense | |||
Net income | |||
Net income (non-controlling interests) | ( | ( | |
Net income (controlling interest) | $ | $ | |
Average shares outstanding (basic) | |||
Average shares outstanding (diluted) | |||
Earnings per share (basic) | $ | $ | |
Earnings per share (diluted) | $ | $ |
For the Three Months Ended March 31, | |||
2024 | 2025 | ||
Net income | $ | $ | |
Other comprehensive income (loss), net of tax: | |||
Foreign currency translation gain (loss) | ( | ||
Change in net realized and unrealized gain (loss) on derivative financial instruments | |||
Change in net unrealized gain (loss) on available-for-sale debt securities | |||
Other comprehensive income (loss), net of tax | ( | ||
Comprehensive income | |||
Comprehensive income (non-controlling interests) | ( | ( | |
Comprehensive income (controlling interest) | $ | $ |
December 31, 2024 | March 31, 2025 | ||
Assets | |||
Cash and cash equivalents | $ | $ | |
Receivables | |||
Investments | |||
Goodwill | |||
Acquired client relationships (net) | |||
Equity method investments in Affiliates (net) | |||
Fixed assets (net) | |||
Other assets | |||
Total assets | $ | $ | |
Liabilities and Equity | |||
Payables and accrued liabilities | $ | $ | |
Debt | |||
Deferred tax liability (net) | |||
Other liabilities | |||
Total liabilities | |||
Commitments and contingencies (Note 7) | |||
Redeemable non-controlling interests | |||
Equity: | |||
Common stock ($ 2024 and March 31, 2025) | |||
Additional paid-in capital | |||
Accumulated other comprehensive loss | ( | ( | |
Retained earnings | |||
Less: Treasury stock, at cost ( March 31, 2025, respectively) | ( | ( | |
Total stockholders' equity | |||
Non-controlling interests | |||
Total equity | |||
Total liabilities and equity | $ | $ |
Three Months Ended March 31, 2024 | Total Stockholders’ Equity | |||||||||||||
Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Loss | Retained Earnings | Treasury Stock at Cost | Non- controlling Interests | Total Equity | ||||||||
December 31, 2023 | $ | $ | $( | $ | $( | $ | $ | |||||||
Net income | — | — | — | — | ||||||||||
Other comprehensive income (loss), net of tax | — | — | — | — | ( | |||||||||
Share-based compensation | — | — | — | — | — | |||||||||
Common stock issued under share-based incentive plans | — | ( | — | — | — | ( | ||||||||
Share repurchases, inclusive of excise tax | — | — | — | — | ( | — | ( | |||||||
Dividends ($ | — | — | — | ( | — | — | ( | |||||||
Affiliate equity activity: | ||||||||||||||
Affiliate equity compensation | — | — | — | — | ||||||||||
Issuances | — | ( | — | — | — | |||||||||
Purchases | — | — | — | — | ( | ( | ||||||||
Changes in redemption value of Redeemable non- controlling interests | — | ( | — | — | — | — | ( | |||||||
Capital contributions and other | — | — | — | — | — | ( | ( | |||||||
Distributions to non-controlling interests | — | — | — | — | — | ( | ( | |||||||
March 31, 2024 | $ | $ | $( | $ | $( | $ | $ |
Three Months Ended March 31, 2025 | Total Stockholders’ Equity | |||||||||||||
Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Loss | Retained Earnings | Treasury Stock at Cost | Non- controlling Interests | Total Equity | ||||||||
December 31, 2024 | $ | $ | $( | $ | $( | $ | $ | |||||||
Net income | — | — | — | — | ||||||||||
Other comprehensive income (loss), net of tax | — | — | ( | — | — | ( | ||||||||
Share-based compensation | — | — | — | — | — | |||||||||
Common stock issued under share-based incentive plans | — | ( | — | — | — | ( | ||||||||
Share repurchases, inclusive of excise tax | — | — | — | — | ( | — | ( | |||||||
Dividends ($ | — | — | — | ( | — | — | ( | |||||||
Affiliate equity activity: | ||||||||||||||
Affiliate equity compensation | — | — | — | — | ||||||||||
Issuances | — | ( | — | — | — | |||||||||
Purchases | — | ( | — | — | — | ( | ( | |||||||
Changes in redemption value of Redeemable non- controlling interests | — | ( | — | — | — | — | ( | |||||||
Capital contributions and other | — | — | — | — | — | ( | ( | |||||||
Distributions to non-controlling interests | — | — | — | — | — | ( | ( | |||||||
March 31, 2025 | $ | $ | $( | $ | $( | $ | $ |
For the Three Months Ended March 31, | |||
2024 | 2025 | ||
Cash flow from (used in) operating activities: | |||
Net income | $ | $ | |
Adjustments to reconcile Net income to cash flow from (used in) operating activities: | |||
Intangible amortization and impairments | |||
Depreciation and other amortization | |||
Deferred income tax expense | |||
Equity method income (net) | ( | ( | |
Distributions received from equity method investments | |||
Share-based compensation and Affiliate equity compensation expense | |||
Net realized and unrealized gains on investment securities | ( | ( | |
Other non-cash items | ( | ( | |
Changes in assets and liabilities: | |||
Purchases of securities by consolidated Affiliate sponsored investment products | ( | ( | |
Sales of securities by consolidated Affiliate sponsored investment products | |||
Increase in receivables | ( | ( | |
Decrease (increase) in other assets | ( | ||
Increase in payables, accrued liabilities, and other liabilities | |||
Cash flow from operating activities | |||
Cash flow from (used in) investing activities: | |||
Investments in Affiliates, net of cash acquired | ( | ||
Purchase of fixed assets | ( | ( | |
Purchase of investment securities | ( | ( | |
Maturities and sales of investment securities | |||
Cash flow from (used in) investing activities | ( | ||
Cash flow from (used in) financing activities: | |||
Borrowings of junior subordinated notes | |||
Repayments of senior bank debt and senior notes | ( | ||
Repurchases of common stock, net | ( | ( | |
Dividends paid on common stock | ( | ( | |
Distributions to non-controlling interests | ( | ( | |
Affiliate equity purchases, net | ( | ( | |
Redemptions of consolidated Affiliate sponsored investment products, net | ( | ( | |
Other financing items | ( | ( | |
Cash flow used in financing activities | ( | ( | |
Effect of foreign currency exchange rate changes on cash and cash equivalents | ( | ||
Net decrease in cash and cash equivalents | ( | ( | |
Cash and cash equivalents at beginning of period | |||
Effect of consolidation of Affiliate sponsored investment products | |||
Cash and cash equivalents at end of period | $ | $ |
December 31, 2024 | March 31, 2025 | |||
Investments in marketable securities | ||||
Equity securities | $ | $ | ||
Debt securities | ||||
Total investments in marketable securities | ||||
Other investments | ||||
Investments measured at NAV as a practical expedient | $ | $ | ||
Investments without readily determinable fair values | ||||
Total other investments | ||||
Investments | $ | $ |
December 31, 2024 | March 31, 2025 | |||
Cost | $ | $ | ||
Unrealized gains | ||||
Unrealized losses | ( | ( | ||
Fair value | $ | $ |
Trading | ||||
December 31, 2024 | March 31, 2025 | |||
Cost | $ | $ | ||
Unrealized losses | ( | ( | ||
Fair value | $ | $ |
December 31, 2024 | March 31, 2025 | ||||||
Fair Value | Unfunded Commitments | Fair Value | Unfunded Commitments | ||||
Investments with limited liquidity(1) | $ | $ | $ | $ | |||
Investments with periodic liquidity(2) | |||||||
Total(3) | $ | $ | $ | $ |
December 31, 2024 | March 31, 2025 | ||
Cost | $ | $ | |
Cumulative unrealized gains | |||
Carrying amount | $ | $ |
For the Three Months Ended March 31, | ||||||||||||
2024 | 2025 | |||||||||||
Measured at NAV as a Practical Expedient | Without Readily Determinable Fair Values | Total | Measured at NAV as a Practical Expedient | Without Readily Determinable Fair Values | Total | |||||||
Balance, beginning of period | $ | $ | $ | $ | $ | $ | ||||||
Purchases and commitments | ||||||||||||
Sales and distributions | ( | ( | ( | ( | ||||||||
Net realized and unrealized gains | ||||||||||||
Balance, end of period | $ | $ | $ | $ | $ | $ |
Fair Value Measurements | |||||||
December 31, 2024 | |||||||
Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||
Financial Assets | |||||||
Investments in equity securities(1) | $ | $ | $ | $ | |||
Investments in debt securities(1) | |||||||
Financial Liabilities(2) | |||||||
Contingent payment obligations | $ | $ | $ | $ | |||
Affiliate equity purchase obligations |
Fair Value Measurements | |||||||
March 31, 2025 | |||||||
Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||
Financial Assets | |||||||
Investments in equity securities(1) | $ | $ | $ | $ | |||
Investments in debt securities(1) | |||||||
Financial Liabilities(2) | |||||||
Contingent payment obligations | $ | $ | $ | $ | |||
Affiliate equity purchase obligations |
For the Three Months Ended March 31, | ||||||||
2024 | 2025 | |||||||
Contingent Payment Obligations | Affiliate Equity Purchase Obligations | Contingent Payment Obligations | Affiliate Equity Purchase Obligations | |||||
Balance, beginning of period | $ | $ | $ | $ | ||||
Purchases and issuances(1) | ||||||||
Settlements and reductions | ( | ( | ||||||
Net realized and unrealized (gains) losses(2) | ( | ( | ( | |||||
Balance, end of period | $ | $ | $ | $ | ||||
Net change in unrealized (gains) losses relating to instruments still held at the reporting date(1) | $( | $( | $( | $ |
Quantitative Information about Level 3 Fair Value Measurements | |||||||||||||||
December 31, 2024 | March 31, 2025 | ||||||||||||||
Valuation Techniques | Unobservable Input | Fair Value | Range | Weighted Average(1) | Fair Value | Range | Weighted Average(1) | ||||||||
Contingent payment obligations | Monte Carlo Simulation | Volatility | $ | $ | |||||||||||
Discount rates | |||||||||||||||
Affiliate equity purchase obligations | Discounted cash flow | Growth rates(2) | $ | ( | $ | ( | |||||||||
Discount rates |
December 31, 2024 | March 31, 2025 | ||||||||
Carrying Value | Fair Value | Carrying Value | Fair Value | Fair Value Hierarchy | |||||
Senior notes | $ | $ | $ | $ | Level 2 | ||||
Junior subordinated notes | Level 2 | ||||||||
Junior convertible securities | Level 2 |
December 31, 2024 | March 31, 2025 | ||||||
Unconsolidated VIE Net Assets | Carrying Value and Maximum Exposure to Loss | Unconsolidated VIE Net Assets | Carrying Value and Maximum Exposure to Loss | ||||
Affiliates accounted for under the equity method | $ | $ | $ | $ |
December 31, 2024 | March 31, 2025 | ||||||
Unconsolidated VIE Net Assets | Carrying Value and Maximum Exposure to Loss | Unconsolidated VIE Net Assets | Carrying Value and Maximum Exposure to Loss | ||||
Affiliate sponsored investment products | $ | $ | $ | $ |
December 31, 2024 | March 31, 2025 | ||
Senior bank debt | $ | $ | |
Senior notes | |||
Junior subordinated notes | |||
Junior convertible securities | |||
Debt | $ | $ |
2025 Senior Notes | 2030 Senior Notes | 2034 Senior Notes | ||||
Issue date | February 2015 | June 2020 | August 2024 | |||
Maturity date | August 2025 | June 2030 | August 2034 | |||
Par value (in millions) | $ | $ | $ | |||
Stated coupon | ||||||
Coupon frequency | Semi-annually | Semi-annually | Semi-annually | |||
Call price | As defined | As defined | As defined |
2059 Junior Subordinated Notes | 2060 Junior Subordinated Notes | 2061 Junior Subordinated Notes | 2064 Junior Subordinated Notes | |||||
Issue date | March 2019 | September 2020 | July 2021 | March 2024 | ||||
Maturity date | March 2059 | September 2060 | September 2061 | March 2064 | ||||
Par value (in millions) | $ | $ | $ | $ | ||||
Stated coupon | ||||||||
Coupon frequency | Quarterly | Quarterly | Quarterly | Quarterly | ||||
Call price | As defined | As defined | As defined | As defined | ||||
NYSE Symbol | MGR | MGRB | MGRD | MGRE |
For the Three Months Ended March 31, | ||||
2024 | 2025 | |||
Contractual interest expense | $ | $ | ||
Amortization of debt issuance costs | ||||
Total | $ | $ | ||
Effective interest rate |
Goodwill | ||
Balance, as of December 31, 2024 | $ | |
Foreign currency translation | ||
Balance, as of March 31, 2025 | $ |
Acquired Client Relationships (Net) | |||||||||
Definite-lived | Indefinite-lived | Total | |||||||
Gross Book Value | Accumulated Amortization | Net Book Value | Net Book Value | Net Book Value | |||||
Balance, as of December 31, 2024 | $ | $( | $ | $ | $ | ||||
Intangible amortization and impairments | — | ( | ( | ( | ( | ||||
Foreign currency translation | ( | ( | |||||||
Balance, as of March 31, 2025 | $ | $( | $ | $ | $ |
Equity Method Investments in Affiliates (Net) | |
Balance, as of December 31, 2024(1) | $ |
Investments in Affiliates | |
Earnings, net of tax | |
Intangible amortization and impairments | ( |
Distributions of earnings | ( |
Foreign currency translation | ( |
Balance, as of March 31, 2025(1) | $ |
For the Three Months Ended March 31, | |||
2024 | 2025 | ||
Share-based compensation expense | $ | $ | |
Tax benefit |
Restricted Stock Units | Weighted Average Grant Date Value Per Unit | ||
Unvested units—December 31, 2024 | $ | ||
Units granted | |||
Units vested | ( | ||
Units forfeited | ( | ||
Performance condition changes | |||
Unvested units—March 31, 2025 | $ |
Stock Options | Weighted Average Exercise Price Per Option | Weighted Average Remaining Contractual Life (Years) | |||
Unexercised options outstanding—December 31, 2024 | $ | ||||
Options granted | |||||
Options exercised | ( | ||||
Options forfeited | |||||
Options expired | ( | ||||
Performance condition changes | |||||
Unexercised options outstanding—March 31, 2025 | $ | ||||
Exercisable at March 31, 2025 | $ |
Redeemable Non-controlling Interests | ||
Balance, as of December 31, 2024(1) | $ | |
Increase attributable to consolidated Affiliate sponsored investment products | ||
Transfers to Other liabilities | ( | |
Changes in redemption value | ||
Balance, as of March 31, 2025(1) | $ |
For the Three Months Ended March 31, | |||
2024 | 2025 | ||
Controlling interest | $ | $ | |
Non-controlling interests | |||
Total | $ | $ |
Controlling Interest | Remaining Life | Non-controlling Interests | Remaining Life | ||||
December 31, 2024 | $ | $ | |||||
March 31, 2025 |
For the Three Months Ended March 31, | |||
2024 | 2025 | ||
Net income (controlling interest) | $ | $ | |
(Decrease) increase in controlling interest paid-in capital from Affiliate equity issuances | ( | ||
Decrease in controlling interest paid-in capital from Affiliate equity purchases | ( | ( | |
Net income (controlling interest) including the net impact of Affiliate equity transactions | $ | $ |
For the Three Months Ended March 31, | |||
2024 | 2025 | ||
Controlling interest(1) | $ | $ | |
Non-controlling interests | |||
Income tax expense | $ | $ | |
Income before income taxes (controlling interest) | $ | $ | |
Effective tax rate (controlling interest)(2) |
For the Three Months Ended March 31, | |||
2024 | 2025 | ||
Numerator | |||
Net income (controlling interest) | $ | $ | |
Income (loss) from hypothetical settlement of Redeemable non-controlling interests, net of taxes | ( | ||
Interest expense on junior convertible securities, net of taxes | |||
Net income (controlling interest), as adjusted | $ | $ | |
Denominator | |||
Average shares outstanding (basic) | |||
Effect of dilutive instruments: | |||
Stock options and restricted stock units | |||
Hypothetical issuance of shares to settle Redeemable non-controlling interests | |||
Junior convertible securities | |||
Average shares outstanding (diluted) |
For the Three Months Ended March 31, | |||
2024 | 2025 | ||
Stock options and restricted stock units | |||
Shares issuable to settle Redeemable non-controlling interests |
For the Three Months Ended March 31, | |||||||||||
2024 | 2025 | ||||||||||
Pre-Tax | Tax (Expense) Benefit | Net of Tax | Pre-Tax | Tax Benefit | Net of Tax | ||||||
Foreign currency translation gain (loss) | $ | $( | $ | $( | $ | $( | |||||
Change in net realized and unrealized gain (loss) on derivative financial instruments | |||||||||||
Change in net unrealized gain (loss) on available-for-sale debt securities | ( | ||||||||||
Other comprehensive income (loss) | $ | $( | $ | $( | $ | $( |
Foreign Currency Translation Adjustment | Realized and Unrealized Gains on Derivative Financial Instruments | Unrealized Gains (Losses) on Available- for-Sale Debt Securities | Total | ||||
Balance, as of December 31, 2024 | $( | $ | $( | $( | |||
Other comprehensive income (loss) before reclassifications | ( | ( | |||||
Amounts reclassified | |||||||
Net other comprehensive income (loss) | ( | ( | |||||
Balance, as of March 31, 2025 | $( | $ | $ | $( |
As of and for the Three Months Ended March 31, | ||||||
(in billions, except as noted) | 2024 | 2025 | % Change | |||
Assets under management | $699.4 | $712.2 | 2% | |||
Average assets under management | 680.0 | 712.1 | 5% | |||
Aggregate fees (in millions) | 1,471.6 | 1,270.4 | (14)% |
Alternatives | Differentiated Long-Only | |||||||||
(in billions) | Private Markets | Liquid Alternatives | Equities(1) | Multi-Asset & Fixed Income | Total | |||||
December 31, 2024 | $135.4 | $140.7 | $316.2 | $115.6 | $707.9 | |||||
Client cash inflows and commitments | 3.5 | 15.9 | 8.8 | 4.8 | 33.0 | |||||
Client cash outflows | (0.1) | (5.7) | (22.5) | (5.1) | (33.4) | |||||
Net client cash flows | 3.4 | 10.2 | (13.7) | (0.3) | (0.4) | |||||
New investments | 1.7 | — | — | — | 1.7 | |||||
Market changes | 0.4 | 2.4 | (2.0) | (0.3) | 0.5 | |||||
Foreign exchange(2) | 0.3 | 1.5 | 1.7 | 0.2 | 3.7 | |||||
Realizations and distributions (net) | (0.9) | (0.0) | (0.1) | (0.1) | (1.1) | |||||
Other(3) | — | 0.0 | 0.0 | (0.1) | (0.1) | |||||
March 31, 2025 | $140.3 | $154.8 | $302.1 | $115.0 | $712.2 |
AUM Weight | % of AUM Ahead of Benchmark(1) | |||||
IRR Latest Vintage | IRR Last Three Vintages | |||||
Private markets(2) | 20% | 86% | 86% |
AUM Weight | % of AUM Ahead of Benchmark(1) | |||||||
3-year | 5-year | 10-year | ||||||
Liquid alternatives(3) | 22% | 78% | 95% | 85% | ||||
Equities(3) | 42% | 44% | 46% | 69% | ||||
Multi-asset and fixed income(4) | 16% | N/A | N/A | N/A |
For the Three Months Ended March 31, | ||||||
(in millions) | 2024 | 2025 | % Change | |||
Net income | $198.7 | $99.2 | (50)% | |||
Net income (controlling interest) | 149.8 | 72.4 | (52)% | |||
Adjusted EBITDA (controlling interest)(1) | 259.8 | 228.2 | (12)% | |||
Economic net income (controlling interest)(1) | 186.7 | 158.7 | (15)% |
For the Three Months Ended March 31, | |||||
(in millions, except as noted) | 2024 | 2025 | % Change | ||
Consolidated Affiliate average assets under management (in billions) | $393.7 | $396.5 | 1% | ||
Consolidated revenue | $499.9 | $496.6 | (1)% |
For the Three Months Ended March 31, | |||||
% Change | |||||
(in millions) | 2024 | 2025 | |||
Compensation and related expenses | $240.4 | $230.3 | (4)% | ||
Selling, general and administrative | 91.7 | 94.7 | 3% | ||
Intangible amortization and impairments | 7.3 | 83.3 | N.M.(1) | ||
Interest expense | 29.9 | 34.1 | 14% | ||
Depreciation and other amortization | 3.0 | 2.8 | (7)% | ||
Other expenses (net) | 9.0 | 11.7 | 30% | ||
Total consolidated expenses | $381.3 | $456.9 | 20% |
For the Three Months Ended March 31, | |||||
(in millions, except as noted) | 2024 | 2025 | % Change | ||
Operating Performance Measures | |||||
Equity method Affiliate average assets under management (in billions) | $286.3 | $315.6 | 10% | ||
Equity method revenue | $971.7 | $773.8 | (20)% | ||
Financial Performance Measures | |||||
Pre-tax equity method earnings | $142.4 | $99.5 | (30)% | ||
Equity method intangible amortization | (20.8) | (18.6) | (11)% | ||
Equity method income tax | (4.1) | (5.6) | 37% | ||
Equity method income (net) | $117.5 | $75.3 | (36)% |
For the Three Months Ended March 31, | |||||
(in millions) | 2024 | 2025 | % Change | ||
Investment and other income | $18.0 | $11.6 | (36)% |
For the Three Months Ended March 31, | |||||
(in millions) | 2024 | 2025 | % Change | ||
Income tax expense | $55.4 | $27.4 | (51)% |
For the Three Months Ended March 31, | |||||
(in millions) | 2024 | 2025 | % Change | ||
Net income | $198.7 | $99.2 | (50)% | ||
Net income (non-controlling interests) | 48.9 | 26.8 | (45)% | ||
Net income (controlling interest) | 149.8 | 72.4 | (52)% |
For the Three Months Ended March 31, | |||
(in millions) | 2024 | 2025 | |
Net income (controlling interest) | $149.8 | $72.4 | |
Interest expense | 29.9 | 34.1 | |
Income taxes(1) | 57.4 | 30.3 | |
Intangible amortization and impairments(2) | 25.6 | 85.8 | |
Other items(3) | (2.9) | 5.6 | |
Adjusted EBITDA (controlling interest) | $259.8 | $228.2 |
For the Three Months Ended March 31, | |||
(in millions) | 2024 | 2025 | |
Consolidated intangible amortization and impairments | $7.3 | $83.3 | |
Consolidated intangible amortization and impairments (non-controlling interests) | (2.5) | (16.1) | |
Equity method intangible amortization and impairments | 20.8 | 18.6 | |
Total | $25.6 | $85.8 |
For the Three Months Ended March 31, | |||
(in millions, except per share data) | 2024 | 2025 | |
Net income (controlling interest) | $149.8 | $72.4 | |
Intangible amortization and impairments(1) | 25.6 | 85.8 | |
Intangible-related deferred taxes(2) | 16.3 | (0.7) | |
Other economic items(3) | (5.0) | 1.2 | |
Economic net income (controlling interest) | $186.7 | $158.7 | |
Average shares outstanding (diluted) | 40.1 | 32.6 | |
Hypothetical issuance of shares to settle Redeemable non-controlling interests | (3.6) | (0.4) | |
Assumed issuance of junior convertible securities shares | (1.7) | (1.7) | |
Average shares outstanding (adjusted diluted) | 34.8 | 30.5 | |
Economic earnings per share | $5.37 | $5.20 |
For the Three Months Ended March 31, | |||
(in millions) | 2024 | 2025 | |
Operating cash flow | $209.2 | $208.9 | |
Investing cash flow | 74.5 | (35.6) | |
Financing cash flow | (302.3) | (316.9) |
(in millions) | December 31, 2024 | March 31, 2025 | |
Senior bank debt | $— | $— | |
Senior notes | 1,097.4 | 1,097.5 | |
Junior subordinated notes | 1,216.0 | 1,216.0 | |
Junior convertible securities | 341.7 | 341.7 |
2025 Senior Notes | 2030 Senior Notes | 2034 Senior Notes | ||||
Issue date | February 2015 | June 2020 | August 2024 | |||
Maturity date | August 2025 | June 2030 | August 2034 | |||
Par value (in millions) | $350.0 | $350.0 | $400.0 | |||
Stated coupon | 3.50% | 3.30% | 5.50% | |||
Coupon frequency | Semi-annually | Semi-annually | Semi-annually |
2059 Junior Subordinated Notes | 2060 Junior Subordinated Notes | 2061 Junior Subordinated Notes | 2064 Junior Subordinated Notes | |||||
Issue date | March 2019 | September 2020 | July 2021 | March 2024 | ||||
Maturity date | March 2059 | September 2060 | September 2061 | March 2064 | ||||
Par value (in millions) | $300.0 | $275.0 | $200.0 | $450.0 | ||||
Stated coupon | 5.875% | 4.75% | 4.20% | 6.75% | ||||
Coupon frequency | Quarterly | Quarterly | Quarterly | Quarterly | ||||
NYSE Symbol | MGR | MGRB | MGRD | MGRE |
Period | Total Number of Shares Purchased(1) | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Average Price Paid Per Share | Maximum Number of Shares that May Yet Be Purchased Under Outstanding Plans or Programs(2) | |||||
January 1-31, 2025 | 240,757 | $184.70 | 240,757 | $184.70 | 5,049,833 | |||||
February 1-28, 2025 | 300,656 | 171.02 | 300,656 | 171.02 | 4,749,177 | |||||
March 1-31, 2025 | 470,453 | 163.98 | 470,453 | 163.98 | 4,278,724 | |||||
Total | 1,011,866 | 171.00 | 1,011,866 | 171.00 |
Exhibit No. | Description | |
10.1 | ||
10.2 | ||
31.1 | ||
31.2 | ||
32.1 | ||
32.2 | ||
101 | The following financial statements from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 are filed herewith, formatted in XBRL (Inline eXtensible Business Reporting Language): (i) the Consolidated Statements of Income for the three-month periods ended March 31, 2025 and 2024, (ii) the Consolidated Statements of Comprehensive Income for the three-month periods ended March 31, 2025 and 2024, (iii) the Consolidated Balance Sheets at March 31, 2025 and December 31, 2024, (iv) the Consolidated Statements of Changes in Equity for the three-month periods ended March 31, 2025 and 2024, (v) the Consolidated Statements of Cash Flows for the three-month periods ended March 31, 2025 and 2024, and (vi) the Notes to the Consolidated Financial Statements | |
104 | The cover page from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, formatted in XBRL (Inline eXtensible Business Reporting Language) and contained in Exhibit 101 |
AFFILIATED MANAGERS GROUP, INC. (Registrant) | |
May 8, 2025 | /s/ DAVA E. RITCHEA |
Dava E. Ritchea on behalf of the Registrant as Chief Financial Officer (and also as Principal Financial and Principal Accounting Officer) |
QuickLinks |